Salazopyrin EN-TABS 500 MG · DIN 02064472 · 500 mg · enteric-coated tablet
General benefitMarketed · checked November 17, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
1 brand, same coverage
Salazopyrin EN-TABS 500 MG · DIN 02064472
Manufacturer: Pfizer Canada Inc.; listing date 1996-10-01
Health Canada: Marketed since 2009-02-03 · brand SALAZOPYRIN EN-TABS 500 MG · ATC A07EC01 SULFASALAZINE · form Tablet (enteric-coated) · route Oral · ingredients SULFASALAZINE 500 MG · company Mavlab animal health ltd · schedule Prescription
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02064472)
Source record
DIN 02064472: Salazopyrin EN-TABS 500 MG
Raw flags: sec3=Y
Item: 082400006; group id 122; item number 0205; lccId None; manufacturer id PFI
Source form: Ent Tab; strength: 500mg
Recorded listing: General benefit
Source prices (unrounded): $0.5616; ministry $0.3863
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02064472
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=17417
Interchangeable products
PMS-Sulfasalazine-E.C. · DIN 00598488 · $0.3863
Shortage status: not checked (no credentials)